||WO||WO/2014/033503 - FREE-WHEELING, FREE-STEERING, FOLDABLE MULTI-STAGE TRICYCLE WITH A SINGLE-MOTION RELEASE MECHANISM||06.03.2014||
||PCT/IB2012/054531||ENIGMA POP PRODUCTS & GIFTS LTD.||HERZEL, Gadi|
A foldable tricycle, including a front wheel assembly; a mainframe, latched to the front wheel assembly via a front mount; a pair of rear-wheel assemblies; a pair of folding ring assemblies coupling the rear-wheel assemblies to the mainframe; and a mechanism for simultaneously unlocking the pair of ring assemblies and unlatching the mainframe from the front wheel assembly so that a single pulling motion on the mechanism unlocks and unlatches the foldable tricycle from an assembled state thereof so as to be converted to a folded state thereof
||WO||WO/2013/118238 - CONNECTABLE BLOCK||15.08.2013||
||PCT/JP2012/052600||Artec Co.,Ltd.||UNO Yasumasa|
The present invention relates to a block that has a simple shape by itself but is capable of providing various three-dimensional structures through the devising of connected states. The block according to the present invention is a regular hexahedron block in which a projection projecting from a surface of one block is fit into a recess disposed in a surface of another block so that at least two blocks can be coupled with each other. On one surface of the hexahedron, one protrusion that has a square-shaped cross section is formed at a center of one segment which is obtained by dividing the flat surface into four equal parts. On the other three surfaces of the hexahedron, the recess into which the projection can be fit is formed at the center of each of the two to four segments which is obtained by dividing the flat surface into the four equal parts.
||WO||WO/2013/098672 - ALPHA1-PROTEINASE INHIBITOR FOR DELAYING THE ONSET OR PROGRESSION OF PULMONARY EXACERBATIONS||04.07.2013||
||PCT/IB2012/056616||GRIFOLS, S.A.||FORSHAG, Mark|
Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations. Described herein are methods for delaying the onset or diminishing the progression of pulmonary exacerbations by the administration of inhaled alpha1-proteinase inhibitor.
||WO||WO/2013/093671 - IDENTIFICATION OF ATYPICAL ANTIBODIES IN HUMAN BLOOD AND BLOOD PRODUCTS||27.06.2013||
||PCT/IB2012/056629||GRIFOLS, S.A.||ZERVOS, Clark|
Described herein is a method for identifying atypical antibodies in blood or blood product manufacturing processes that may produce false positives in quality control testing on intermediate or final products.
||WO||WO/2013/080446 - METHOD OF PROVIDING CONTROL INFORMATION FOR USER EQUIPMENT IN LTE COMMUNICATION SYSTEM||06.06.2013||
||PCT/JP2012/007118||NEC CORPORATION||NGUYEN, Phong|
There is provided a method implemented in a base station (11) of providing control information to a UE (13) over a wireless communications system (10). This method includes: scrambling (32) an E-PDCCH including the control information; modulating the E-PDCCH; mapping (34) the E-PDCCH on an allocated PRB; and transmitting (12) the E-PDCCH to the UE (13). The UE (13) communicates over the wireless communications system (10) according to the control information.
||WO||WO/2013/080801 - TANTALUM SPUTTERING TARGET AND METHOD FOR MANUFACTURING SAME||06.06.2013||
||PCT/JP2012/079598||JX NIPPON MINING & METALS CORPORATION||SENDA Shinichiro|
This tantalum sputtering target is characterized by the orientation ratio for (200) surfaces being 70% or less and the orientation ratio for (222) surfaces being 10% or greater on a sputtering surface on a tantalum sputtering target. The sputtering rate can be increased by controlling the crystal orientation of the target, and by this means, film growth of a necessary film thickness can be carried out in a short period of time, making improvements in throughput possible.
||WO||WO/2013/075029 - CONDENSED IMIDAZOLYLIMIDAZOLES AS ANTIVIRAL COMPOUNDS||23.05.2013||
||PCT/US2012/065681||GILEAD SCIENCES, INC.||BACON, Elizabeth, M.|
The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
||WO||WO/2013/058723 - COMPONENT CARRIER REEL SPLICING TAPE||25.04.2013||
||PCT/US2011/022314||ROME, Patrick||ROME, Patrick|
A splicing tape for accurately aligning and joining spliced component carrier reels is disclosed. The flexible splice tape allows the components to remain aligned and picked from a component carrier reel without interruption at the union of a first and second reel. The splice tape with an optional stiffening strip provides a flexible, yet strong connection to prevent back and forth, axial and lateral movement between spliced reels. The detection of the disclosed splice tape facilitates elimination of incorrect and mismatched components during splicing. The splice tape comprises a plastic-type material coated on one side with a pressure-sensitive adhesive composition. A protective paper covers the adhesive composition. The splice tape and protective paper are divided into sections using a staggered slit arrangement. The staggered slit arrangement aids in proper alignment and adhesion of the splice tape to component carrier reels.
||WO||WO/2013/057281 - MODULATION OF MACROPHAGE ACTIVATION||25.04.2013||
||PCT/EP2012/070805||TRANSGENE SA||HAEGEL, Hélène|
The invention is generally directed to promoting Ml-type (macrophage M1 polarization) immune response by administering a compound that modulates macrophage activation. The invention is directed to the use of an antibody able to bind to CSF-IR for modulating macrophage activation. The invention is also directed to methods for evaluating the dose efficacy of an antibody able to bind to CSF-IR in a patient by assessing the in vivo or in vitro activation of macrophages. The invention is further directed to post-treatment companion test and assays to assess the effect of an antibody able to bind to CSF-IR on a subject being treated.
||WO||WO/2013/056947 - PROCESS FOR PREPARING EXPANDED COPOLYMERS BASED ON POLY(METH)ACRYLIMIDE COMPRISING AN ADHESION PROMOTER||25.04.2013||
||PCT/EP2012/068885||EVONIK RÖHM GMBH||BÜHLER, Sebastian|
The invention relates to a process for producing a foam moulding from poly(meth)acrylimide, an adhesion promoter or an adhesion promoter mixture and optionally assistants, comprising the following steps: - grinding a polymer moulding composed of poly(meth)acrylimide, - coating the ground material obtained in the preceding step with an adhesion promoter, - introducing the coated ground material into a mould, - optionally adding the assistants, - heating the mould, - cooling the mould at foaming temperature - demoulding the foam moulding. The resulting foam moulding has outstanding mechanical properties and is suitable, inter alia, as a component for production of space, air, water and land vehicles.